- Cool Tool – The Human Protein AtlasPosted 7 days ago
- Optimization of Roche Liberase MNP-S GMP Grade in the Enzymatic Digestion of Human Umbilical Cord for the Isolation of Mesenchymal Stem CellsPosted 1 week ago
- Ask the Expert – Maximizing Transient Protein ProductionPosted 1 week ago
- Enabling Viral Vector Production and Vaccine Manufacturing using the iCELLis – a single-use, automated, and closed manufacturing platformPosted 2 weeks ago
- Cell Culture Basics – Mycoplasma 101 – A practical guide to prevention, detection and elimination of mycoplasma contaminationPosted 3 weeks ago
- Going to BPI West 2017? Don’t miss these great talks and activities!Posted 4 weeks ago
- Cool Tool – PRIME-XV® T Cell CDM – First Commercially Available Chemically-defined, Animal-component-free Medium for T Cell CulturePosted 4 weeks ago
- Increasing Protein Production with Novel Cell-Ess Titer Boost without Affecting the Metabolic ProfilePosted 1 month ago
- Continuous Processing Optimization with Smarter ToolsPosted 1 month ago
- Cool Tool – Generation of Neural Stem Cells from AlphaSTEM Cultured Pluripotent Stem CellsPosted 1 month ago
The Dish’s Weekly News Wrap Up – May 11, 2012
The biological therapeutics sold by Amgen and other companies are produced by bacteria or cultured mammalian cells. Even though researchers and companies have been manufacturing drugs in this manner for decades, there is still a lot to be learned about the biology of a cell
If you like this story, please see our blog titled “Strategies for Improving Antibody Production in CHO Cells”
Experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval, under a proposal likely to become law this year.
If you like this story, please see our blog titled “CHO Cells the Top Expression System of Best Selling Biologic Drugs”
Drug makers could strike big with new treatments for rare diseases, according to a new report by a market research firm.
If you like this story, please see our blog titled “Alternatives to Fetal Bovine Serum in Cell Culture Media, Challenges and Perspectives”
Researchers who found a way to rejuvenate aged blood-forming cells in mice say their achievement offers clues about how it may be possible to combat health problems associated with old age. The study by scientists at Cincinnati Children’s Hospital Medical Center and Ulm University Medicine in Germany appeared online May 3 in the journal Cell Stem Cell.
If you like this story, please see our blog titled “Culture and Expansion of Stem Cells in Stirred Suspension Bioreactors Could Provide Key in Large Scale Manufacturing”
HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies, according to a study that scientists say proves the treatment may safely be tested as a way to attack other illnesses.
If you like this story, please see our stem cell blog titled “Fetal Stem Cells Could be Most Effecitve in Heart Treatment”
Pluristem Therapeutics Inc said a 7-year old girl suffering from a bone marrow disease experienced a reversal of her condition after receiving its experimental stem cell therapy, sending the Israeli company’s shares up 32 percent.
If you like this story, please see our blog titled “Exciting Treatment Possibilities With Stem Cells What is the Best Cell Culture Method”
Three patients with amyotrophic lateral sclerosis will be permitted to receive a second dose of stem cells delivered directly to the spinal cord, in a clinical trial being led by the University of Michigan’s Eva Feldman, M.D.
If you like this story, please see our blog titled “Neonatal Stem Cells for Research and Clinical Applications”